z-logo
open-access-imgOpen Access
Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections
Author(s) -
Alba Ruedas-López,
Isaac Alonso-García,
Cristina Lasarte-Monterrubio,
Paula Guijarro-Sánchez,
Eva Gato,
Juan Carlos Vázquez-Ucha,
Juán A. Vallejo,
Pablo A. Fraile-Ribot,
Begoña Fernández-Pérez,
David Velasco,
José María Gutiérrez-Urbón,
Marina Oviaño,
Alejandro Beceiro,
Concepción GonzálezBello,
Antonio Oliver,
Jorge Arca-Suárez,
Germán Bou
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02067-21
Subject(s) - ceftazidime/avibactam , pseudomonas aeruginosa , ceftazidime , tazobactam , microbiology and biotechnology , avibactam , drug resistance , medicine , beta lactamase inhibitors , biology , antibiotics , antibiotic resistance , bacteria , imipenem , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom